Phage therapy is a type of treatment that uses viruses called bacteriophages to fight bacterial infections. These tiny viruses specifically target and kill the bacteria causing the illness. It's a natural way to help your body get rid of harmful bacteria.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Phage therapy treats bacterial infections with bacteriophages (phages for short), viruses that infect and destroy bacteria but do not infect human cells. A phage attaches to a bacterium, multiplies inside it and bursts it open, releasing new phages that can go on to attack nearby bacteria of the same kind. Phages are highly selective. Each one usually kills only certain strains of a single bacterial species, so a phage that works against one person's infection may do nothing against another's. That precision is both the appeal and the challenge: phages can target bacteria that resist antibiotics while leaving the body's other bacteria largely alone, but they must be matched to the specific bacteria causing the infection. Phages are usually given together with antibiotics, and the two can sometimes work better in combination than either does alone.
Phage therapy is mainly considered for serious, persistent bacterial infections that have not cleared with standard antibiotics, often because the bacteria are resistant to several drugs. Examples include chronic lung infections (including in people with cystic fibrosis), infections of bone or around artificial joints and implants, hard-to-heal wound infections and recurring urinary infections. In the United States, phage therapy is not approved by the Food and Drug Administration (FDA). It is available only through clinical trials or through expanded access (sometimes called compassionate use), a pathway in which the FDA permits an unapproved treatment for an individual patient with a serious condition and no satisfactory alternative. It is not a treatment for viral illnesses such as colds or flu, because phages act only on bacteria.
The process usually starts with an infectious disease specialist. A sample of the bacteria causing the infection is sent to a phage laboratory, where it is tested against collections of phages to find ones that kill that particular strain. If suitable phages are found, they are purified and prepared for medical use, and the treating team requests permission to use them, through a clinical trial or an FDA expanded access application. Finding and preparing a match can take time, and sometimes no effective phage is found. Phages are generally delivered as close to the infection as possible: inhaled through a nebulizer for lung infections, applied to wounds, placed directly into an infected bone or joint during surgery or through a catheter, or instilled into the bladder. Some patients receive them by intravenous infusion. Treatment courses in published case series have ranged from several days to several weeks, usually in a hospital or specialist setting and usually alongside antibiotics.
Because phage therapy is offered case by case, the experience varies widely with the infection, the route of delivery and the center providing it. Monitoring typically includes repeated cultures to see whether the targeted bacteria are decreasing, along with the usual tests for the underlying infection. Response is not predictable. Some people improve and clear the infection; others improve without the bacteria fully disappearing, and some do not benefit. Bacteria can become resistant to a phage during treatment, and the immune system can produce antibodies that neutralize phages, particularly when they are given intravenously or directly into tissue. When this happens, the team may switch to different phages or rely more on antibiotics. Interestingly, bacteria that become resistant to a phage sometimes become easier to treat with antibiotics.
Phage therapy has been studied for about a century and is used more routinely in Georgia and Russia, but evidence that meets current standards is still limited. The largest recent report followed 100 people treated case by case in 12 countries for difficult infections, mostly in the lungs, skin and bone. Doctors reported clinical improvement in about three quarters of infections and elimination of the targeted bacteria in about 60%. These results are encouraging but come without a comparison group, and most patients were also receiving antibiotics. In that series, bacteria were much less likely to be eliminated when antibiotics were not used alongside phages. Randomized controlled trials, which compare treatments head to head, have been disappointing so far. In a trial of burn wounds infected with Pseudomonas bacteria, a fixed phage mixture (accidentally given at a much lower strength than intended) reduced bacteria more slowly than standard silver-based burn cream. In a trial of men with urinary infections before prostate surgery, a commercial phage mixture rinsed into the bladder worked no better than a placebo rinse. Researchers think personalized matching, adequate dosing and combining phages with antibiotics may matter, and larger controlled trials are under way, but it is not yet known for which infections phage therapy reliably helps.
Reported side effects have generally been mild and short-lived in published case series and trials, and serious reactions clearly caused by phages appear uncommon. Experience is still small, however, and treatment with a living biological product carries some uncertainty, including possible reactions to impurities from the bacteria the phages are grown in. Intravenous or surgical delivery adds the usual risks of those procedures. Access is a real constraint. Only a handful of centers in the United States offer phage therapy, a match may not be found, and arranging regulatory approval and supply takes time that a rapidly worsening infection may not allow. Phage therapy does not replace effective antibiotics or surgical treatment of an infection. Pre-made phage products sold without prescription in some countries, such as Georgia and Russia, are not matched to a person's bacteria and are not FDA approved, so using them without specialist guidance is not advisable.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience with Phage Therapy, what's helped you, or ask the community a question.